Vagustim
PrivateLast Round
Crowdfunding
Nov 6, 2025
Total Funding Raised
$310,996
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vagustim operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Crowdfunding round in November 2025.
Vagustim is a therapeutic devices company that develops a wearable neuromodulation device designed to electrically stimulate the vagus nerve in both ears.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vagustim Comparables
Compare Vagustim with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Parasym | 91% | |
| ZenoWell | 90% | |
| Neuvana | 86% |
For institutional investors. Book with your work email.
Vagustim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Nov 6, 2025 | ||||
| Grant | Jun 7, 2022 | ||||
| Accelerator | Jan 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vagustim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ITU ARI Teknokent | Seed |
| EIT Health | Accelerator, Grant |
| Eczacıbaşı Momentum | Seed |
| Türkiye Bilimsel ve Teknolojik Araştırma Kurumu | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 31% MoM.
- Aug 10, 2026
Open roles increased to 15, 2.1x the trailing average.
For institutional investors. Book with your work email.
Vagustim Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vagustim's valuation, stock price, and market status.
Is Vagustim a public or private company?
Vagustim is a private company.
What is the current stock price of Vagustim?
Vagustim is a private company, so its shares have no public market price. Caplight tracks Vagustim's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vagustim worth (valuation)?
Valuation information for Vagustim is not publicly available.
Can I buy Vagustim stock?
Vagustim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vagustim's last funding round?
Vagustim's most recent funding round was Crowdfunding on November 6, 2025.
Who are the main investors in Vagustim?
Key investors in Vagustim include ITU ARI Teknokent, EIT Health, Eczacıbaşı Momentum, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Will Vagustim IPO soon?
No public IPO plans have been announced for Vagustim.
How can I track Vagustim secondary market activity?
Caplight tracks bids, offers, and trades in Vagustim's shares on secondary markets.